title: Screening of the endothelin1 gene (EDN1) in a cohort of patients with essential left ventricular hypertrophy.
abstract: Our objective was to analyse the role of endothelin1 gene (EDN1) variation in essential left ventricular hypertrophy (LVH). We searched for EDN1 variants in 145 Spanish patients with an essential form of LVH (not secondary to hypertension, aortic stenosis, or any other disease that could explain the hypertrophy). The five EDN1 coding exons and 1.5 kilobases of the promoter region were analysed through single strand conformation analysis and direct sequencing. We found four nucleotide changes: -1224 C/A (promoter), -131 ins/del A (exon 1, 5'-non-translated sequence), A/G in codon 106 (exon 3, silent), and G/T in codon 198 (exon 5, lys198asn). To determine the association between these polymorphisms and cardiac hypertrophy, we compared the genotype frequencies from these 145 patients with 250 healthy controls. We found a higher frequency of patients homozygous for 198 lys (198 KK) (65% vs. 52%; p = 0.01; OR = 1.76) and for -1224 AA (73% vs. 66%; p = 0.19). Homozygotes for -1224 A + 198 K (AA+KK) were significantly more frequent in patients (62% vs. 45%; p = 0.0007; OR = 2.10; 95% CI = 1.35-3.25). The expression of the -1224 C/A and exon 5 K198N variants was analysed with cells in culture. These in vitro studies showed that these variations did not differ in their expression levels. In conclusion, our work has shown that EDN1 variation, and in particular homozygosity for the -1224A/198K haplotype, is associated with the risk of developing cardiac hypertrophy. However, these EDN1 variants do not affect in vitro gene expression.
authors.affiliation: Genética Molecular, Hopital Central Asturias, Oviedo, Spain.
authors.forename: M G
authors.initials: MG
authors.lastname: Castro
authors.forename: F
authors.initials: F
authors.lastname: Rodríguez-Pascual
authors.forename: N
authors.initials: N
authors.lastname: Magán-Marchal
authors.forename: J R
authors.initials: JR
authors.lastname: Reguero
authors.forename: C
authors.initials: C
authors.lastname: Alonso-Montes
authors.forename: C
authors.initials: C
authors.lastname: Morís
authors.forename: V
authors.initials: V
authors.lastname: Alvarez
authors.forename: S
authors.initials: S
authors.lastname: Lamas
authors.forename: E
authors.initials: E
authors.lastname: Coto
mesh_terms: D000293:Adolescent; D000328:Adult; D019943:Amino Acid Substitution / Q000235:genetics; D019332:Endothelin-1 / Q000235:genetics*; D005260:Female; D006239:Haplotypes; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D017354:Point Mutation
chemical_list: D019332:Endothelin-1